nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—forelimb—amyotrophic lateral sclerosis	0.0477	0.134	CbGeAlD
Pemetrexed—ATIC—hindlimb—amyotrophic lateral sclerosis	0.0429	0.121	CbGeAlD
Pemetrexed—ATIC—appendage—amyotrophic lateral sclerosis	0.0368	0.104	CbGeAlD
Pemetrexed—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0457	CcSEcCtD
Pemetrexed—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0382	CcSEcCtD
Pemetrexed—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0354	CcSEcCtD
Pemetrexed—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0148	0.033	CcSEcCtD
Pemetrexed—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0321	CcSEcCtD
Pemetrexed—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0321	CcSEcCtD
Pemetrexed—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0305	CcSEcCtD
Pemetrexed—GART—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.0127	0.065	CbGpPWpGaD
Pemetrexed—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0283	CcSEcCtD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.0125	0.0636	CbGpPWpGaD
Pemetrexed—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0276	CcSEcCtD
Pemetrexed—ATIC—embryo—amyotrophic lateral sclerosis	0.0122	0.0344	CbGeAlD
Pemetrexed—GART—medulla oblongata—amyotrophic lateral sclerosis	0.0115	0.0324	CbGeAlD
Pemetrexed—ATIC—brainstem—amyotrophic lateral sclerosis	0.0112	0.0315	CbGeAlD
Pemetrexed—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0232	CcSEcCtD
Pemetrexed—GART—spinal cord—amyotrophic lateral sclerosis	0.0103	0.0289	CbGeAlD
Pemetrexed—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0227	CcSEcCtD
Pemetrexed—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0227	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.0101	0.0518	CbGpPWpGaD
Pemetrexed—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0197	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00885	0.0452	CbGpPWpGaD
Pemetrexed—ATIC—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00882	0.045	CbGpPWpGaD
Pemetrexed—GART—nervous system—amyotrophic lateral sclerosis	0.00864	0.0243	CbGeAlD
Pemetrexed—SLC46A1—spinal cord—amyotrophic lateral sclerosis	0.00832	0.0234	CbGeAlD
Pemetrexed—GART—central nervous system—amyotrophic lateral sclerosis	0.00832	0.0234	CbGeAlD
Pemetrexed—DHFR—embryo—amyotrophic lateral sclerosis	0.00821	0.0231	CbGeAlD
Pemetrexed—GART—cerebellum—amyotrophic lateral sclerosis	0.00813	0.0229	CbGeAlD
Pemetrexed—DCK—embryo—amyotrophic lateral sclerosis	0.0071	0.02	CbGeAlD
Pemetrexed—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00702	0.0156	CcSEcCtD
Pemetrexed—SLC46A1—nervous system—amyotrophic lateral sclerosis	0.00701	0.0197	CbGeAlD
Pemetrexed—ATIC—spinal cord—amyotrophic lateral sclerosis	0.00696	0.0196	CbGeAlD
Pemetrexed—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00689	0.0153	CcSEcCtD
Pemetrexed—SLC46A1—central nervous system—amyotrophic lateral sclerosis	0.00675	0.019	CbGeAlD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.00668	0.0341	CbGpPWpGaD
Pemetrexed—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00667	0.0149	CcSEcCtD
Pemetrexed—GART—brain—amyotrophic lateral sclerosis	0.0066	0.0186	CbGeAlD
Pemetrexed—SLC46A1—cerebellum—amyotrophic lateral sclerosis	0.0066	0.0186	CbGeAlD
Pemetrexed—GART—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00658	0.0336	CbGpPWpGaD
Pemetrexed—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0146	CcSEcCtD
Pemetrexed—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0064	0.0143	CcSEcCtD
Pemetrexed—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00628	0.014	CcSEcCtD
Pemetrexed—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0139	CcSEcCtD
Pemetrexed—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0135	CcSEcCtD
Pemetrexed—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00599	0.0133	CcSEcCtD
Pemetrexed—ATIC—nervous system—amyotrophic lateral sclerosis	0.00587	0.0165	CbGeAlD
Pemetrexed—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0127	CcSEcCtD
Pemetrexed—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0127	CcSEcCtD
Pemetrexed—ATIC—central nervous system—amyotrophic lateral sclerosis	0.00565	0.0159	CbGeAlD
Pemetrexed—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0125	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0056	0.0125	CcSEcCtD
Pemetrexed—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0056	0.0125	CcSEcCtD
Pemetrexed—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0124	CcSEcCtD
Pemetrexed—ATIC—cerebellum—amyotrophic lateral sclerosis	0.00552	0.0155	CbGeAlD
Pemetrexed—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0054	0.012	CcSEcCtD
Pemetrexed—SLC46A1—brain—amyotrophic lateral sclerosis	0.00536	0.0151	CbGeAlD
Pemetrexed—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00533	0.0119	CcSEcCtD
Pemetrexed—DHFR—medulla oblongata—amyotrophic lateral sclerosis	0.00524	0.0148	CbGeAlD
Pemetrexed—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0114	CcSEcCtD
Pemetrexed—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00509	0.0113	CcSEcCtD
Pemetrexed—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0113	CcSEcCtD
Pemetrexed—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00502	0.0112	CcSEcCtD
Pemetrexed—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0108	CcSEcCtD
Pemetrexed—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00479	0.0107	CcSEcCtD
Pemetrexed—DHFR—spinal cord—amyotrophic lateral sclerosis	0.00468	0.0132	CbGeAlD
Pemetrexed—DCK—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00458	0.0234	CbGpPWpGaD
Pemetrexed—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0102	CcSEcCtD
Pemetrexed—DCK—medulla oblongata—amyotrophic lateral sclerosis	0.00454	0.0128	CbGeAlD
Pemetrexed—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00453	0.0101	CcSEcCtD
Pemetrexed—ATIC—brain—amyotrophic lateral sclerosis	0.00448	0.0126	CbGeAlD
Pemetrexed—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00994	CcSEcCtD
Pemetrexed—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00973	CcSEcCtD
Pemetrexed—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00919	CcSEcCtD
Pemetrexed—DCK—spinal cord—amyotrophic lateral sclerosis	0.00405	0.0114	CbGeAlD
Pemetrexed—Syncope—Riluzole—amyotrophic lateral sclerosis	0.004	0.00891	CcSEcCtD
Pemetrexed—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00399	0.0089	CcSEcCtD
Pemetrexed—TYMS—nervous system—amyotrophic lateral sclerosis	0.00398	0.0112	CbGeAlD
Pemetrexed—DHFR—nervous system—amyotrophic lateral sclerosis	0.00394	0.0111	CbGeAlD
Pemetrexed—TYMS—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00393	0.0201	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00874	CcSEcCtD
Pemetrexed—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00858	CcSEcCtD
Pemetrexed—TYMS—central nervous system—amyotrophic lateral sclerosis	0.00383	0.0108	CbGeAlD
Pemetrexed—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00846	CcSEcCtD
Pemetrexed—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00846	CcSEcCtD
Pemetrexed—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00846	CcSEcCtD
Pemetrexed—DHFR—central nervous system—amyotrophic lateral sclerosis	0.00379	0.0107	CbGeAlD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0084	CcSEcCtD
Pemetrexed—TYMS—cerebellum—amyotrophic lateral sclerosis	0.00374	0.0105	CbGeAlD
Pemetrexed—DHFR—cerebellum—amyotrophic lateral sclerosis	0.00371	0.0104	CbGeAlD
Pemetrexed—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00811	CcSEcCtD
Pemetrexed—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00811	CcSEcCtD
Pemetrexed—Infection—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00806	CcSEcCtD
Pemetrexed—Shock—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00798	CcSEcCtD
Pemetrexed—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00796	CcSEcCtD
Pemetrexed—SLC29A1—nervous system—amyotrophic lateral sclerosis	0.00357	0.01	CbGeAlD
Pemetrexed—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00794	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00355	0.0181	CbGpPWpGaD
Pemetrexed—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00788	CcSEcCtD
Pemetrexed—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00773	CcSEcCtD
Pemetrexed—SLC29A1—central nervous system—amyotrophic lateral sclerosis	0.00344	0.00967	CbGeAlD
Pemetrexed—DCK—nervous system—amyotrophic lateral sclerosis	0.00341	0.0096	CbGeAlD
Pemetrexed—SLC29A1—cerebellum—amyotrophic lateral sclerosis	0.00336	0.00945	CbGeAlD
Pemetrexed—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00739	CcSEcCtD
Pemetrexed—DCK—central nervous system—amyotrophic lateral sclerosis	0.00328	0.00924	CbGeAlD
Pemetrexed—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00723	CcSEcCtD
Pemetrexed—TYMS—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00321	0.0164	CbGpPWpGaD
Pemetrexed—DCK—cerebellum—amyotrophic lateral sclerosis	0.00321	0.00903	CbGeAlD
Pemetrexed—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00714	CcSEcCtD
Pemetrexed—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00705	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00314	0.007	CcSEcCtD
Pemetrexed—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00699	CcSEcCtD
Pemetrexed—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00694	CcSEcCtD
Pemetrexed—Pain—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00694	CcSEcCtD
Pemetrexed—TYMS—brain—amyotrophic lateral sclerosis	0.00304	0.00856	CbGeAlD
Pemetrexed—DHFR—brain—amyotrophic lateral sclerosis	0.00301	0.00848	CbGeAlD
Pemetrexed—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00663	CcSEcCtD
Pemetrexed—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00644	CcSEcCtD
Pemetrexed—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00641	CcSEcCtD
Pemetrexed—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00641	CcSEcCtD
Pemetrexed—SLC29A1—brain—amyotrophic lateral sclerosis	0.00273	0.00768	CbGeAlD
Pemetrexed—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00598	CcSEcCtD
Pemetrexed—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00582	CcSEcCtD
Pemetrexed—DCK—brain—amyotrophic lateral sclerosis	0.00261	0.00734	CbGeAlD
Pemetrexed—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00574	CcSEcCtD
Pemetrexed—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00555	CcSEcCtD
Pemetrexed—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00536	CcSEcCtD
Pemetrexed—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00516	CcSEcCtD
Pemetrexed—Rash—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00511	CcSEcCtD
Pemetrexed—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00511	CcSEcCtD
Pemetrexed—GART—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00229	0.0117	CbGpPWpGaD
Pemetrexed—GART—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00229	0.0117	CbGpPWpGaD
Pemetrexed—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00482	CcSEcCtD
Pemetrexed—GART—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00209	0.0107	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00201	0.0103	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.002	0.0102	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.002	0.0102	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00198	0.0101	CbGpPWpGaD
Pemetrexed—GART—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00194	0.00993	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.0019	0.00972	CbGpPWpGaD
Pemetrexed—GART—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00183	0.00933	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00171	0.00872	CbGpPWpGaD
Pemetrexed—GART—Metabolism—DAO—amyotrophic lateral sclerosis	0.00165	0.00844	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00163	0.00833	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00158	0.00809	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00158	0.00809	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00158	0.00809	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00152	0.00777	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00148	0.00754	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TPK1—amyotrophic lateral sclerosis	0.00147	0.00753	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00145	0.0074	CbGpPWpGaD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.00144	0.00735	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00135	0.00688	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00129	0.00657	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00127	0.00647	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00125	0.0064	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00123	0.0063	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00123	0.0063	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—VTA1—amyotrophic lateral sclerosis	0.00118	0.00602	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GSR—amyotrophic lateral sclerosis	0.00116	0.0059	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—DAO—amyotrophic lateral sclerosis	0.00115	0.00585	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00113	0.00577	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00112	0.00573	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00109	0.00559	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00109	0.00559	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00109	0.00556	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00107	0.00546	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00105	0.00536	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00104	0.00534	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00102	0.00523	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00102	0.00521	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000998	0.0051	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000987	0.00504	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000975	0.00498	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000949	0.00485	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000905	0.00462	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000905	0.00462	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000893	0.00456	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000892	0.00456	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000871	0.00445	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000868	0.00443	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000868	0.00443	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000868	0.00443	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000824	0.00421	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000824	0.00421	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000809	0.00413	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000809	0.00413	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PLB1—amyotrophic lateral sclerosis	0.000808	0.00412	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSR—amyotrophic lateral sclerosis	0.000801	0.00409	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000791	0.00404	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TPK1—amyotrophic lateral sclerosis	0.00079	0.00404	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00079	0.00403	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00079	0.00403	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000774	0.00395	CbGpPWpGaD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.000772	0.00394	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.00077	0.00393	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000753	0.00385	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—VCP—amyotrophic lateral sclerosis	0.00072	0.00368	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000706	0.00361	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000706	0.00361	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0007	0.00358	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000688	0.00351	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000676	0.00345	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000672	0.00343	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000667	0.00341	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000662	0.00338	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000662	0.00338	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000658	0.00336	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000658	0.00336	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000637	0.00325	CbGpPWpGaD
Pemetrexed—DHFR—Disease—VTA1—amyotrophic lateral sclerosis	0.000632	0.00323	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000624	0.00319	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000605	0.00309	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.0006	0.00307	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—DAO—amyotrophic lateral sclerosis	0.000595	0.00304	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000578	0.00295	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000578	0.00295	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000573	0.00293	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000572	0.00292	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000563	0.00287	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000529	0.0027	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000528	0.0027	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CST3—amyotrophic lateral sclerosis	0.000517	0.00264	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000513	0.00262	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00051	0.00261	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000491	0.00251	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000479	0.00245	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—DAO—amyotrophic lateral sclerosis	0.000479	0.00244	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000469	0.00239	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000462	0.00236	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000459	0.00235	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000451	0.0023	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PLB1—amyotrophic lateral sclerosis	0.000433	0.00221	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000433	0.00221	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DAO—amyotrophic lateral sclerosis	0.000418	0.00213	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSR—amyotrophic lateral sclerosis	0.000416	0.00213	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000401	0.00205	CbGpPWpGaD
Pemetrexed—DHFR—Disease—VCP—amyotrophic lateral sclerosis	0.000386	0.00197	CbGpPWpGaD
Pemetrexed—GART—Metabolism—APOE—amyotrophic lateral sclerosis	0.000386	0.00197	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CASP9—amyotrophic lateral sclerosis	0.000376	0.00192	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000363	0.00185	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000359	0.00183	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000354	0.00181	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000342	0.00175	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSR—amyotrophic lateral sclerosis	0.000335	0.00171	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000333	0.0017	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000325	0.00166	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000322	0.00164	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000316	0.00162	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSR—amyotrophic lateral sclerosis	0.000292	0.00149	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000283	0.00144	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CST3—amyotrophic lateral sclerosis	0.000277	0.00141	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000275	0.00141	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000275	0.0014	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOE—amyotrophic lateral sclerosis	0.000267	0.00137	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000264	0.00135	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000253	0.00129	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOE—amyotrophic lateral sclerosis	0.000249	0.00127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00024	0.00122	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000214	0.00109	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000208	0.00106	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000205	0.00105	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CASP9—amyotrophic lateral sclerosis	0.000201	0.00103	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000184	0.000939	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000183	0.000935	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB4—amyotrophic lateral sclerosis	0.000172	0.00088	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—amyotrophic lateral sclerosis	0.00017	0.00087	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000169	0.000863	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000148	0.000754	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000143	0.000729	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOE—amyotrophic lateral sclerosis	0.000139	0.00071	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000136	0.000693	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOE—amyotrophic lateral sclerosis	0.000133	0.000681	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000129	0.000658	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000118	0.000605	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOE—amyotrophic lateral sclerosis	0.000112	0.00057	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000106	0.000541	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOE—amyotrophic lateral sclerosis	9.75e-05	0.000498	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.52e-05	0.000486	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—amyotrophic lateral sclerosis	9.25e-05	0.000472	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—amyotrophic lateral sclerosis	9.14e-05	0.000467	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.65e-05	0.000391	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.68e-05	0.000341	CbGpPWpGaD
